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Nasopharyngeal carcinoma (NPC), the major cancer killer in Cantonese Chinese, represents
one of the three cancer research priorities in China. Apart from some fundamental research
projects on the Epstein-Barr virus (EBV), their main efforts are epidemiologically and clinically
oriented. Major surveys in GuangDong and GuangXi provinces showed that high EBV/
IgA/VCA serum levels can detect NPC at an early stage of the disease. Characterization of
precancerous lesions" in the nasopharynx and among the EBV/IgA positive individuals is in
progress in the Zangwu county of the GuangXi Autonomous Region. Preventive anti-viral
intervention in these individuals is being discussed. Search for genetic and environmental
chemical carcinogens is also carried out. This Chinese epidemiological approach complements
well the fundamental Western studies on EBV and NPC.
INTRODUCTION
As a major national effort, a comprehensive cancer survey was undertaken in the
People's Republic of China, between 1974 and 1976. It covered the 29 provinces,
2,392 counties and involved a population of 850 million individuals. The results are
being published in an atlas of Cancer Mortality in China by Dr. Li Ping, Head ofthe
National Cancer Control Office ofthe Ministry ofHealth and Director ofthe Cancer
Research Institute of the Chinese Academy of Medical Sciences, Peking [1]. The
order of frequency for the country and the geographical preponderance of the
700,000 tumors detected annually in the People's Republic of China is shown in
Table 1.
Three cancer sites show a specific geographical distribution and were declared
research priorities at the national level: cancer of the esophagus in the north central
area, under the responsibility of the Cancer Institute of the Academy of Medical
Sciences in Peking; primary liver carcinoma in the southeastern area, under the
coordination of the Shanghai Cancer Institute; and nasopharyngeal carcinoma in the
south, under the chairmanship of the Guangzhou Cancer Institute.
Setting medical research priorities is a must in developing countries, but in China
there is much more to it. The Chinese priorities are mainly geared toward primary
and secondary prevention; i.e., toward the characterization of risk factors (that will
have to be eliminated) and early detection through major mass surveys. While
Western nations have a "curative" health system and an analytical research mind,
Chinese tend to consider prevention as the only valuable health approach and a
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Rank of Frequency by Sites and Geographical Distribution of Cancer in China, 1974-1977
(from the Cancer Institute, Peking, Dr. Li Ping)
Order of Frequency
at the National Level Organ Site Geographical Preponderance
1 stomach Northeast provinces
2 esophagus Centralpart-south of Peking
3 liver Shanghai and southeast
4 cervix Central China, Hupei Province
5 lung Northeast and southeast coasts
6 colon No special geographical distribution
7 leukemias/lymphomas No special geographical distribution
8 nasopharynx GuangDong province and surrounding areas
9 breast No special geographical distribution
pragmatic way to control diseases without necessarily knowing their precise etiology
or pathogenesis.
This approach, which goes back thousands of years, is leading at the present time
to multifactorial intervention in high-risk communities in a most pragmatic manner,
even before having well delimited the risk factors. In 1949, top priority was given to
health problems. In the cancer field, the results ofDoll[2], indicatingthe critical role
ofthe environment and life style in the development of most carcinomas, were taken
as the basis of a cancer research program. The Chinese decided that the best waywas
to define risk factors and to set up preventive interventions. China thus offers the
possibility of conducting epidemiological studies unthinkable in the Western world.
Post-Mao China is changing rapidly, and fundamental research has been quickly
reinstalled in most cancer centers. This may promote a well-balanced, integrated,
fundamental and applied research program.
The content ofthe present paper refers to information gathered duringa visit to the
main Chinese cancer centers in July 1979 and during a collaborativefield study trip in
Zangwu County of the GuangXi Autonomous Region with Dr. Zeng and collabora-
tors in April-May 1980.
EPIDEMIOLOGY OF NASOPHARYNGEAL CARCINOMA (NPC) IN CHINA
Figure 1 shows the dramatic geographical restriction of the NPC distribution in
South China [1]. In GuangDong province, which represents more than 50 million
individuals, NPC is the most common type ofcancer. It represents 43 percent of all
cancers in males and 16 percent in females [3]. The minimal age-adjusted prevalence
rate for NPC during the period 1970-1972 was found to be 40/100,000 and
23/100,000 for males and females, respectively [4].
Of particular interest was the geographical variation observed in GuangDong
province. The central and southern parts ofGuangDong province exhibit the highest
rate for NPC and correspond relatively well to the Pearl River Basin inhabited by
Cantonese, the main ethnic group in size, with an incidence rate of NPC of 10 to
20/100,000 per year.
The Tanka or boat-dwellers of the Pearl River are at an even higher risk for this
cancer (incidence = 55/ 100,000 per year); theChao-Chow, living in the northeast part
of the province, and the Hakka, northern migrants, both have an intermediate risk
for NPC (incidence = 5 to 10/100,000 per year) [Li Chen Chuan, personal communi-
cation]. Such geographical variations most probably reflect dietary and cultural
customs.
In the adjacent GuangXi Autonomous Region, NPC is prevalent mostly in the
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FIG. 1. Geographic variations of the mortality rates for nasopharyngeal carcinoma (NPC) in
the People's Republic of China. The dark areas refer to the highest prevalence, where NPC
represents up to 43 percent of all cancers in males. In these areas, centered on GuangDong
province and extending along the South China Sea's shores in Fujian province, the crude
annual mortality rates range from 11 to 25 per 100,000 inhabitants. The shaded areas refer to
intermediate prevalence of NPC, with annual mortality rates varying from 2 to 10 per 100,000
inhabitants. These cover part of the GuangXi Autonomous Region and the provinces of
Hunan, JiangXi, and Fujian. (Source: Dr. Li Ping: Atlas of cancer mortality in the People's
Republic of China. Edited by the Cancer Institute, Chinese Academy of Medical Sciences.
Beijing, in press)
eastern part inhabited bythe Han, which includes theZangwu Countywhere an NPC
field station has been set up.
Along the western Pearl River, the NPC incidence is comparable to that of
Guangzhou. In the province ofHunan, adjoiningGuangDong to the north, NPC has
a relatively low incidence, except in the Miao western area, where NPC is high.
Such ageographical distribution suggests astrong environmental or rather cultural
factor, possibly linked to nutrition, such as nitrosamine-contaminated fishes.
35SEARCH FOR CHEMICAL CARCINOGENS
Whereas this field of research has been very active in relation to the cancer of the
esophagus in the central part ofChina with the evidence ofnitrosamines and nitrates
in pickled vegetables, only minor efforts have been devoted to similar studies with
regard to nasopharyngeal carcinoma.
Ho [5-6] has repeatedly claimed that the cultural habits of the Cantonese Chinese
in eating salted fish is linked to the risk of developing nasopharyngeal carcinoma.
Huang et al. [7-8] found nitrosamines in such salted fish and succeeded in inducing
tumors of the nasal fossae in rats fed with salted fish. The belief of Ho in such a
cultural factor is so strong that a few years ago he launched a vigorous public
campaign to prevent mothers from giving such delicate food to weaning babies.
Chinese epidemiologists in Shanghai, Changsha, or Kwangchow do not believe that
this habit could represent an important risk factor, as the areas where this habit is
very common do not correspond systematically to the areas with high NPC
incidence. However, Dr. Pan Chih-Cheng of the Human Medical College in
Changsha has, together with Dr. Yas Kai Pai, carried out studies on nitrosamines in
rats, in line with Ho's results.
By inoculating 50 mg-kg weight of nitroso-piperazine compound subcutaneously
in rats, she obtained tumors of the nasal fossae, of the esophagus, and of the liver
[personal communication]. Unfortunately, noepidemiological study has been carried
out, to our knowledge, in China, comparing the salted fish eating habit in popula-
tions with high and low risk for NPC. Zangwu County oftheGuangXiAutonomous
Region, with neighboring populations exhibiting high and low risks for nasopharyn-
geal carcinoma, would be suitable for such studies.
VIROLOGICAL STUDIES
Whereas in the Occidental World most studies on theEpstein-Barr virus (EBV) are
related to fundamental research [9-12], the Chinese priorities are geared to a better
control of nasopharyngeal carcinoma using the association with EBV. This led to
epidemiologically oriented and clinical research projects on early diagnosis, with
laboratory support. Cancer research institutes and basic virus laboratories are
progressively implementing new basic virological (cell biology and molecular)
projects on EBV, mostly in Peking (Institute of Virology and Cancer Institute), in
Shanghai (Institute of Cell Biology), and in Guangzhou(Cancer Institute) but also in
universities, such as the Hunan Medical College in Changsha. Pertinent to this point
is the world's first success in obtaining an established epithelial NPC-derived cell line
[13]. Population-oriented studies on NPC have focused first on patients evaluating
the strength of the EBV association by serology, IgG antibodies to Virion Capsid
Antigens (VCA), Early Antigens (EA), and Epstein-Barr Nuclear Antigens (EBNA),
and then on mass population surveys to assess the usefulness of EBV serology to
detect NPC at a very early stage of the disease, when treatment is less expensive and
more efficient. For such a purpose they developed immunoenzymatic tests for
detecting antibodies to VCA, EA, and EBNA in field conditions [15-16].
Population surveys involved two steps: first, serological surveys aimed at detecting
individuals with high IgA antibodies to VCA, then clinical surveys aimed at
characterizing pre-NPC lesions of the nasopharynx [14]. Two major studies were
carried out in that direction in South China. Around Guangzhou, Dr. Li Chen
Chuan of the GuangDong Cancer Hospital and Cancer Institute (Director, Dr.
Tseung) organized a massive clinical survey involving more than 32,000 normal
individuals. On carefully examining 494 nasopharyngeal mucosae, they found 48
36 G. DE-THETHE CHINESE APPROACH IN NPC RESEARCH AND CONTROL
nodular alterations ofthe mucosa, 28 hyperplastic adenoids, 9 follicular hyperplasias,
4 cases with numerous petechia, and 5 atrophic mucosae, two ofthem beingfound to
be NPC [Dr. Li and Dr. Tseung, personal communication].
In the eastern part of the GuangXi Aunotomous Region, Dr. Zeng of the Virus
Institute in Peking, in collaboration with the GuangXi Department ofPublic Health,
surveyed in the Zangwu county a total of 148,000 normal individuals aged 30 years
and above. By the immunoenzymatic test they developed [15] and in two successive
studies, Zeng et al. found around 1,300 individuals with IgA/VCA titers 1:25 or
higher [17]. Clinical investigations of these individuals led to the finding of46 NPC
cases, about one-half at early stages (I and II) ofthe disease[16; Zeng etal., personal
communication]. Careful follow-up of these IgA-positive individuals showed that
one and a half years after the original clinical survey, 12 more developed NPC,
indicating a minimal incidence of 250 per 100,000 among the IgA-positive individu-
als, more than twenty times higher than that of the general population of the same
area (20/100,000) [Zeng et al., personal communication]. Clinical examination of
1,150 of these IgA-positive individuals showed 335 macroscopic abnormalities ofthe
nasopharyngeal mucosa. Out of 203 biopsies taken on the most obvious abnormali-
ties, histopathological examination showed 78 inflammatory processes, 66 lymphoid
hyperplasia, 46 NPC (see above), and 13 normal mucosae [NPC collaborating group
in Zangwu chaired by Dr. Zeng, personal communication].
In order to better characterize the macroscopic, microscopic, and virological
lesions of the nasopharynx preceeding the development of NPC, we carried out in
April-May 1980, with Dr. Zeng and his collaborators, a detailed investigation of 56
individuals in the Zangwu county Cancer Center selected for their high IgA titers.
Four NPC cases were again discovered and seven inflammatory lesions showed some
EBNA positive cells byACIF test on smears [18; Desgranges et al., in preparation]. A
search for EBV DNA in the collected biopsies in being carried out in collaboration
with Dr. Bornkamm from Dr. Zur Hausen's laboratory in Freiburg, Federal
Republic of Germany. Careful follow-up of these 56 individuals will tell whether
lesions of the nasopharynx with EBV markers do represent pre-cancerous lesions or
not.
In another field study, Zeng et al. [personal communication] are collecting
exfoliated cells from the nasopharyngeal mucosa of NPC and non-NPC individuals,
by negative pressure suction. These mostly epithelial exfoliated cells are being tested
for the presence of EBNA by their immunoenzymatic method [16]. Preliminary
results indicate that EBNA is detectable not only in NPC tumor cells, but also in
hypertrophic and normal-looking epithelial cells [19].
GENETIC STUDIES
Cytogenetic studies have been carried out onNPC-derived lymphoblastoid lines in
Peking Cancer Institute, in Shanghai, Changsha, and in Guangzhou. Giant group A
marker chromosomes have been detected by Chinese investigators in various
proportions ofsuch cell lines [20]. Short-term epithelial outgrowths from NPC have
also shown such cytogenetic abnormalities. Ou et al. in Guangzhou Cancer Institute
reported the presence ofgiant sub meta centric chromosomes in 18 epithelial explants
of48 NPC biopsies put in culture [personal communication]. The major drawback is
the difficulty of obtaining dividing epithelial cells in vitro.
Multiple NPC case families have been searched for at the Guangzhou Cancer
Institute. Ou et al. [personal communication] found that 5 to 6 percent of the NPC
cases seen at the Cancer Hospital are occurring in families where two or more cases of
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NPC have been observed. Unfortunately, the limit of the family is not given. Dr.
Tang in Changhai ENT Hospital is also looking at the same problem and has
observed a number of families with multiple cases [personal communication]. It is
worth noting at this point that there is a taboo about first-cousin marriage on the
paternal side in China, but that this is not the case for cousins from the maternal side.
Ho has repeatedly reported families with multiple cases ofNPC [5-6]. HLA (Human
Leukocyte Antigens) studies in relation to NPC have not yet been fully implemented
in China. One would like to see if the results of Simons et al. [21] who showed that
the haplotype A2BW46 in Chinese carries an increased risk of 2 vis-a-vis the general
population can be extended to China. Dr. Simons is helping to set up an HLA
typing laboratory in the Cancer Institute in Guangzhou. The determination of
different genetic traits including HLA-DR in multiple NPC case families should
bring significant new data on this important question.
PREVENTIVE INTERVENTIONS
As discussed in the introduction to this paper, the main aim ofthe Cancer Control
Program in China is to implement multifactorial interventions with the hope of
somewhere breaking the chain ofevents before the clinical development ofthe tumor.
In the high esophagus cancer areas, populations are discouraged from eatingpickled
vegetables and are advised to add vitamin C to theirfood, thus decreasingthe nitrate
level in their urine. No report to our knowledge is available to assess the value ofthis
intervention.
In the field ofnasopharyngealcarcinoma, little effort is made to tryand discourage
people from eating salted fish in China, in contrast to the effort of Dr. Ho in
Hongkong, who launched a major information campaign to convince parents to stop
giving salted fish to weaned babies. The field studies carried out in the Zangwu
county and the finding of high-risk individuals characterized by high serum
IgA/VCA titers represent a unique opportunity to consider the possibility of a
selected prevention against NPC through antiviral intervention.
The basic hypothesis is that the clinical development ofNPC is accompanied by or
better is preceded by a reactivation of the latent infection by EBV in the nasopharyn-
geal mucosa. Such a reactivation is reflected by the presence ofIgA in the serum and
in the nasopharyngeal mucosa. If one could successfully treat such EBV reactivation
in the nasopharynx, reverse the organism's trend of increasing the serum IgA/VCA
titers, and see if such intervention prevents the development of NPC, the causal
involvement of EBV would be established and a new approach for NPC prevention
achieved. Anti-viral intervention could be carried out either by treatment by inter-
feron or by chemotherapy involving compounds such as acycloguanosine.
An active immunotherapy using cell surface-determined EBV antigens is also a
possibility to be investigated. The feasibility of such interventions remains to be
evaluated from the experimental as well as the epidemiological and ethical view-
points. But the Chinese approach to cancer research allows such possibilities, and we
are confident that they will succeed in bringing further important epidemiological
studies, in achieving systematic early detection, and we hope in preventing NPC in a
reasonable period of time.
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